{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:49:27Z","timestamp":1765547367013,"version":"3.35.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.cca.2025.120127","type":"journal-article","created":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:39Z","timestamp":1736294439000},"page":"120127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Validation and performance of MicroVue sC5b-9 Plus ELISA on the Dynex DS2 platform"],"prefix":"10.1016","volume":"568","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4064-5420","authenticated-orcid":false,"given":"Rebecca J.","family":"Wilson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcy","family":"Bhandari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane A.","family":"Dickerson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa M.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2025.120127_b0005","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.celrep.2012.02.003","article-title":"Assembly and regulation of the membrane attack complex based on structures of C5b6 and sC5b9","volume":"1","author":"Hadders","year":"2012","journal-title":"Cell Rep."},{"key":"10.1016\/j.cca.2025.120127_b0010","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1053\/j.ajkd.2015.02.326","article-title":"Soluble C5b-9 as a biomarker for complement activation in atypical hemolytic uremic syndrome","volume":"65","author":"Bu","year":"2015","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.cca.2025.120127_b0015","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1007\/s00277-017-3092-9","article-title":"Plasma levels of complement activation fragments C3b and sC5b-9 significantly increased in patients with thrombotic microangiopathy after allogeneic stem cell transplantation","volume":"96","author":"Qi","year":"2017","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.cca.2025.120127_b0020","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13371","article-title":"Transplant-associated thrombotic microangiopathy: incidence, prognostic factors, morbidity, and mortality in allogeneic hematopoietic cell transplantation","volume":"32","author":"Gavriilaki","year":"2018","journal-title":"Clin. Transplant."},{"key":"10.1016\/j.cca.2025.120127_b0025","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1053\/j.seminhematol.2018.04.003","article-title":"Complement in pathophysiology and treatment of transplant-associated thrombotic microangiopathies","volume":"55","author":"Jodele","year":"2018","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.cca.2025.120127_b0030","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.blre.2014.11.001","article-title":"A new paradigm: diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury","volume":"29","author":"Jodele","year":"2015","journal-title":"Blood Rev."},{"key":"10.1016\/j.cca.2025.120127_b0035","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jtct.2022.11.015","volume":"29","author":"Schoettler","year":"2023","journal-title":"Transplant. Cell. Therapy."},{"key":"10.1016\/j.cca.2025.120127_b0040","first-page":"1049","article-title":"Complement blockade for TA-TMA: lessons learned from a large pediatric cohort treated with eculizumab","volume":"135","author":"Jodele","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.cca.2025.120127_b0045","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1007\/s00467-018-4091-3","article-title":"Eculizumab in atypical hemolytic uremic syndrome: strategies toward restrictive use","volume":"34","author":"Wijnsma","year":"2019","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.cca.2025.120127_b0050","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jim.2018.06.010","article-title":"The impact of eculizumab on routine complement assays","volume":"460","author":"Willrich","year":"2018","journal-title":"J. Immunol. Methods."},{"key":"10.1016\/j.cca.2025.120127_b0055","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1080\/10408363.2021.1907297","article-title":"Complement testing in the clinical laboratory","volume":"58","author":"Willrich","year":"2021","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"10.1016\/j.cca.2025.120127_b0060","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1309\/AJCPXPD7ZQXNTIAL","article-title":"Effect of blood sampling, processing, and storage on the measurement of complement activation biomarkers","volume":"143","author":"Yang","year":"2015","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.cca.2025.120127_b0065","article-title":"Validation of early increase in complement activation marker sC5b-9 as a predictive biomarker for the development of thrombotic microangiopathy after stem cell transplantation","volume":"7","author":"Mez\u00f6","year":"2020","journal-title":"Front. Med. (Lausanne)."},{"key":"10.1016\/j.cca.2025.120127_b0070","unstructured":"MicroVue SC5b-9 Plus EIA IFU PIA020004EN00. Quidel Ortho Diagnostics; 2022."},{"key":"10.1016\/j.cca.2025.120127_b0075","first-page":"15","article-title":"Optimising automation of a manual enzyme-linked immunosorbent assay","volume":"1","author":"de Beer","year":"2012","journal-title":"Afr. J. Lab. Med."},{"key":"10.1016\/j.cca.2025.120127_b0080","article-title":"Validation of the picoAMH assay on the Dynex DS2 platform","volume":"17","author":"Garnett","year":"2019","journal-title":"Pract. Lab. Med."},{"key":"10.1016\/j.cca.2025.120127_b0085","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jim.2016.05.009","article-title":"Novel biomarker and easy to perform ELISA for monitoring complement inhibition in patients with atypical hemolytic uremic syndrome treated with eculizumab","volume":"435","author":"Riedl","year":"2016","journal-title":"J. Immunol. Methods."},{"key":"10.1016\/j.cca.2025.120127_b0090","doi-asserted-by":"crossref","first-page":"6051","DOI":"10.1182\/bloodadvances.2020003471","article-title":"Evidence of thrombotic microangiopathy in children with SARS-CoV-2 across the spectrum of clinical presentations","volume":"4","author":"Diorio","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.cca.2025.120127_b0095","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.3324\/haematol.2022.280603","article-title":"The successful use of eculizumab for treatment of thrombotic microangiopathy in pediatric acute SARSCoV2 infection and multisystem inflammatory syndrome in children","volume":"107","author":"Aurora","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.cca.2025.120127_b0100","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.1713","article-title":"Levels of complement components in children with acute COVID-19 or multisystem inflammatory syndrome","volume":"6","author":"Rajamanickam","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.cca.2025.120127_b0105","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1001\/jamainternmed.2019.4694","article-title":"The clinical trials portfolio for on-label and off-label studies of eculizumab","volume":"180","author":"Kim","year":"2020","journal-title":"JAMA Intern Med."},{"key":"10.1016\/j.cca.2025.120127_b0110","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1002\/ajh.26872","article-title":"Reeling in complement in transplant-associated thrombotic microangiopathy: You\u2019re going to need a bigger boat","volume":"98","author":"Jodele","year":"2023","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.cca.2025.120127_b0115","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.3390\/ijms24021159","article-title":"Transplant-associated thrombotic microangiopathy in the context of allogenic hematopoietic stem cell transplantation: where we stand","volume":"24","author":"Lazana","year":"2023","journal-title":"Int. J. Mol. Sci."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898125000063?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898125000063?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T21:19:33Z","timestamp":1738358373000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898125000063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":23,"alternative-id":["S0009898125000063"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2025.120127","relation":{},"ISSN":["0009-8981"],"issn-type":[{"type":"print","value":"0009-8981"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validation and performance of MicroVue sC5b-9 Plus ELISA on the Dynex DS2 platform","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2025.120127","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"120127"}}